JAK2 and breast carcinoma: Overexpression of STAT4 promoted programmed cell death ligand 1 (PD‐L1) level via the STAT4‐related pathway: IL‐12R/JAK2–STAT3–STAT4/PD‐L1 feedback axis in breast cancer cell.